Tag: Institutional Corruption

“Bernie Sanders Blasts FDA Commish Nominee Califf”

0
Democratic Presidential nominee, Bernie Sanders, questioned the nominee for FDA commissioner, Robert Califf, during yesterday’s Senate hearing. Sanders remarked that we need a commissioner who will stand up to the pharmaceutical companies and protect American consumers. Of Califf, he added, “with regret, I think that you are not that person.”

“Bad Science and Such Big Portions–Drug-Company Funded CMEs Fall Out of...

0
For the USC Center for Health Journalism, Martha Rosenberg points out the absurdity of allowing industry funded doctors to teach classes to practitioners about psychiatric drugs. "What if the written road test drivers take were sponsored by BP or Shell and had marketing messages interspersed?"

“Mental Health Bill Caters to Big Pharma and Would Expand Coercive...

0
Oryx Cohen at TruthOut explains why the "Helping Families in Mental Health Crisis Act (HR 2646) - commonly known as the 'Murphy Bill' - appears to cater more closely to the desires of pharmaceutical companies than to the actual needs of people in psychological distress, perhaps because of Murphy's connections to key lobbyists." "If the Murphy Bill is passed, psychiatric hospitals and pharmaceutical companies will reap huge financial benefits as a result of increased hospitalization and forced treatment."

“Would Washington’s FDA Fix Cure the Patients or the Drug Industry?”

0
Legislation is being advanced that would speed up the FDA’s approval process for new drugs and medical devices, according to a report by the Pacific Standard. Pharmaceutical and medical device companies have been lobbying heavily to reduce regulations and are winning over bipartisan support by attaching these measures to increased mental health funding.

“How Too Much Medicine Can Kill You”

0
In an op-ed for the Guardian, cardiologist Aseem Malhotra writes: “Corporate greed and systematic political failure have brought healthcare to its knees. There are too many misinformed doctors and misinformed patients. It’s time for greater transparency and stronger accountability, so that doctors and nurses can provide the best quality care for the most important person in the consultation room – the patient.”

Massive Number of Antidepressant Meta-Analyses Biased By Industry

4
A massive number of meta-analyses of antidepressant clinical trials have financial conflicts of interest and are unduly influenced by pharmaceutical companies, according to a review to be published in an upcoming issue of the Journal of Clinical Epidemiology. Researchers also found that meta-analyses with industry ties almost never report any negative findings in their abstracts.

Bernie Sanders Opposes Califf for FDA Post Cites Industry Ties

50
Bernie Sanders joins numerous public health groups and opposes Robert Califf's nomination to lead the FDA over industry ties.

Ronald Pies Doubles Down (And Why We Should Care)

119
This past Saturday, I was on my way back from Europe to Boston, and while on a stop in Iceland, I checked my email and was directed to a new blog by Ronald Pies in Psychiatric Times, in which he once again revisited the question of whether American psychiatry, and the American Psychiatric Association (APA), ever promoted the idea that chemical imbalances caused mental disorders. And just like when I read his 2011 writings on this subject, I found myself wondering what to make of his post. Why was he so intent on maintaining psychiatry’s “innocence?” And why did it matter?

 The “Institutional Corruption” of Psychiatry: A Conversation With Authors...

1
Robert Whitaker and Lisa Cosgrove discuss their new book Psychiatry Under the Influence in an interview with psychologist and social critic Bruce Levine for Truthout. In the book, Whitaker and Cosgrove apply the institutional corruption framework, developed by Larry Lessig, to psychiatry and determine that “just as elected officials develop dependency on special interests and become beholden to these funders instead of the citizenry,” psychiatry has “had its social mission subverted by drug companies as well as by the psychiatry guild's self-preservation and expansionism needs.”